bookoff-mcandrews
googleplus--white
linkedin--white
noun_Conversation_1010437
vcard
close
Search for:
Home
Our Team
About Us
Practice Areas
Back
Practice Areas
Patent Prosecution & Portfolio Management
Due Diligence & IP Transactions
Opinions & Counseling
Contested Proceedings
Industry Experience
Back
Industry Experience
Mechanical
Medical Devices & Healthcare IT
Computer & Electrical
Chemistry & Materials
Software & Internet
Consumer Products
Pharmaceuticals & Biotechnology
Manufacturing & Transportation
Energy & Cleantech
Join Us
Contact Us
Diversity
Blog
News
Bookoff McAndrews
Our Team
About Us
Practice Areas
Industry Experience
Join Us
Contact Us
Diversity
Blog
News
Search for:
Blog
June 11, 2019
Federal Courts Not Bound by USPTO § 101 Guidance
Read More
May 16, 2019
A Renewed Focus on Standard Essential Patents
Read More
May 8, 2019
PTAB Designates Precedential Decisions on Identifying the Real Party-in-Interest in Post-Grant Proceedings
Read More
May 1, 2019
USPTO’s Precedential Opinion Panel Weighs in on Joinder in IPR Proceedings
Read More
March 6, 2019
Sovereign Immunity Does Not Shield a State from §101 Patent Eligibility Challenges in Infringement Actions Brought by the State
Read More
February 28, 2019
PTAB Reversals Based On The 2019 Revised Patent Subject Matter Eligibility Guidance
Read More
February 26, 2019
International Design Patent Applications – Another Tool in the Toolbox
Matthew T. Powell
Read More
February 21, 2019
Federal Circuit Provides Guidance on the Limits of Invalidating Under Public Use
Scott Chappell
Read More
February 14, 2019
Taking Another Look at Patent Term Adjustment: Supernus Pharmaceuticals, Inc. v. Iancu
Sangwoo Ahn
Read More
January 25, 2019
Secret Sales Remain Prior Art Under the AIA: Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc.
Read More